MeSH term | MeSH ID | Detail |
---|---|---|
Farber Lipogranulomatosis | D055577 | 1 associated lipids |
Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.
To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Pathway name | Related literatures |
---|
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).
Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).
Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ratner M | Novartis eyes oral MS drug as potential blockbuster. | 2010 | Nat. Biotechnol. | pmid:21057464 |
Ponnusamy S et al. | Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance. | 2010 | Future Oncol | pmid:21062159 |
Dhami R et al. | Acid sphingomyelinase deficiency attenuates bleomycin-induced lung inflammation and fibrosis in mice. | 2010 | Cell. Physiol. Biochem. | pmid:21063112 |
Fox TE et al. | Circulating sphingolipid biomarkers in models of type 1 diabetes. | 2011 | J. Lipid Res. | pmid:21068007 |
Wang L et al. | FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl. | 2011 | Eur. Respir. J. | pmid:21071472 |
Siow DL et al. | Sphingosine kinase localization in the control of sphingolipid metabolism. | 2011 | Adv. Enzyme Regul. | pmid:21075134 |
Jang S et al. | Modulation of sphingosine 1-phosphate and tyrosine hydroxylase in the stress-induced anxiety. | 2011 | Neurochem. Res. | pmid:21076868 |
Hirahara K et al. | Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. | 2010 | Cytokine Growth Factor Rev. | pmid:21084214 |
Hisano Y et al. | The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. | 2011 | J. Biol. Chem. | pmid:21084291 |
Muscoli C et al. | Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids. | 2010 | J. Neurosci. | pmid:21084596 |
Lai WQ et al. | Sphingosine kinase and sphingosine 1-phosphate in asthma. | 2011 | Biosci. Rep. | pmid:21091442 |
Sabbadini RA | Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration. | 2011 | Br. J. Pharmacol. | pmid:21091645 |
Howard C et al. | Dental pulp stem cell migration. | 2010 | J Endod | pmid:21092813 |
Majeed Y et al. | Stereo-selective inhibition of transient receptor potential TRPC5 cation channels by neuroactive steroids. | 2011 | Br. J. Pharmacol. | pmid:21108630 |
Kikuta J et al. | S1P-targeted therapy for elderly rheumatoid arthritis patients with osteoporosis. | 2011 | Rheumatol. Int. | pmid:21113810 |
Hu PF et al. | Sphingosine-1-phosphate: a potential therapeutic target for rheumatoid arthritis. | 2011 | Mol. Biol. Rep. | pmid:21116853 |
Bonnaud S et al. | Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis. | 2010 | Cancer Res. | pmid:21118968 |
Ishii M et al. | Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. | 2010 | J. Exp. Med. | pmid:21135136 |
Bieberich E | There is more to a lipid than just being a fat: sphingolipid-guided differentiation of oligodendroglial lineage from embryonic stem cells. | 2011 | Neurochem. Res. | pmid:21136155 |
Cho MC et al. | Involvement of sphingosine-1-phosphate/RhoA/Rho-kinase signaling pathway in corporal fibrosis following cavernous nerve injury in male rats. | 2011 | J Sex Med | pmid:21143420 |
Li C et al. | Sphingosine 1-phosphate (S1P)/S1P receptors are involved in human liver fibrosis by action on hepatic myofibroblasts motility. | 2011 | J. Hepatol. | pmid:21145832 |
Zhao Y et al. | Protection of LPS-induced murine acute lung injury by sphingosine-1-phosphate lyase suppression. | 2011 | Am. J. Respir. Cell Mol. Biol. | pmid:21148740 |
Jeffery DR et al. | Fingolimod for the treatment of relapsing multiple sclerosis. | 2011 | Expert Rev Neurother | pmid:21158700 |
Chi H | Sphingosine-1-phosphate and immune regulation: trafficking and beyond. | 2011 | Trends Pharmacol. Sci. | pmid:21159389 |
Jee BC et al. | Dose-dependent effect of sphingosine-1-phosphate in mouse oocyte maturation medium on subsequent embryo development. | 2011 | Gynecol. Obstet. Invest. | pmid:21160167 |
Ter Braak M et al. | Cis-4-methylsphingosine is a sphingosine-1-phosphate receptor modulator. | 2011 | Biochem. Pharmacol. | pmid:21163254 |
Markiewicz M et al. | Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells. | 2011 | Microcirculation | pmid:21166920 |
Zhao M et al. | [The effects of sphingosine-1 1-phosphate (SIP) on the action potential and contractile in guinea pig ventricular myocardium]. | 2007 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | pmid:21171361 |
Allende ML et al. | Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. | 2011 | J. Biol. Chem. | pmid:21173151 |
Duan HF et al. | [Establishment of a method for determining the sphingosine kinase activity and its initial application]. | 2005 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | pmid:21180179 |
Zhao M et al. | [The effects of Sphing-1-phosphate(S1P) on the potassium channel of the ventricular myocytes]. | 2009 | Zhongguo Ying Yong Sheng Li Xue Za Zhi | pmid:21186617 |
Sassoli C et al. | Effects of S1P on skeletal muscle repair/regeneration during eccentric contraction. | 2011 | J. Cell. Mol. Med. | pmid:21199328 |
Kim YM et al. | G(alpha)12/13 induction of CYR61 in association with arteriosclerotic intimal hyperplasia: effect of sphingosine-1-phosphate. | 2011 | Arterioscler. Thromb. Vasc. Biol. | pmid:21212405 |
Kharel Y et al. | A rapid assay for assessment of sphingosine kinase inhibitors and substrates. | 2011 | Anal. Biochem. | pmid:21216217 |
Gaveglio VL et al. | Metabolic pathways for the degradation of phosphatidic acid in isolated nuclei from cerebellar cells. | 2011 | Arch. Biochem. Biophys. | pmid:21216221 |
Doyle T et al. | Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats. | 2011 | Pain | pmid:21239112 |
Bouma HR et al. | Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21245336 |
Aarthi JJ et al. | Dissecting the role of the S1P/S1PR axis in health and disease. | 2011 | J. Dent. Res. | pmid:21248363 |
Ulrych T et al. | Release of sphingosine-1-phosphate from human platelets is dependent on thromboxane formation. | 2011 | J. Thromb. Haemost. | pmid:21251196 |
Catarzi S et al. | Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. | 2011 | Biochim. Biophys. Acta | pmid:21256191 |
Dickson MA et al. | A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. | 2011 | Clin. Cancer Res. | pmid:21257722 |
Beljanski V et al. | Antitumor activity of sphingosine kinase 2 inhibitor ABC294640 and sorafenib in hepatocellular carcinoma xenografts. | 2011 | Cancer Biol. Ther. | pmid:21258214 |
Bolli MH et al. | Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls. | 2011 | Curr Top Med Chem | pmid:21261590 |
Hopson KP et al. | S1P activates store-operated calcium entry via receptor- and non-receptor-mediated pathways in vascular smooth muscle cells. | 2011 | Am. J. Physiol., Cell Physiol. | pmid:21270296 |
Lee SY et al. | Sphingosine-1-phosphate reduces hepatic ischaemia/reperfusion-induced acute kidney injury through attenuation of endothelial injury in mice. | 2011 | Nephrology (Carlton) | pmid:21272128 |
Herzog C et al. | Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury. | 2010 | Mediators Inflamm. | pmid:21274265 |
Sumida GM and Stamer WD | S1Pâ‚‚ receptor regulation of sphingosine-1-phosphate effects on conventional outflow physiology. | 2011 | Am. J. Physiol., Cell Physiol. | pmid:21289286 |
Sensken SC et al. | Local inactivation of sphingosine 1-phosphate in lymph nodes induces lymphopenia. | 2011 | J. Immunol. | pmid:21289303 |
Lan T et al. | Simultaneous determination of sphingosine and sphingosine 1-phosphate in biological samples by liquid chromatography-tandem mass spectrometry. | 2011 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:21292568 |
McQuiston T et al. | Role of sphingosine-1-phosphate (S1P) and S1P receptor 2 in the phagocytosis of Cryptococcus neoformans by alveolar macrophages. | 2011 | Microbiology (Reading, Engl.) | pmid:21292747 |
Highkin MK et al. | High-throughput screening assay for sphingosine kinase inhibitors in whole blood using RapidFire® mass spectrometry. | 2011 | J Biomol Screen | pmid:21297110 |
Ding R et al. | Sphingosine-1-phosphate attenuates lung injury induced by intestinal ischemia/reperfusion in mice: role of inducible nitric-oxide synthase. | 2012 | Inflammation | pmid:21302134 |
Berdyshev EV et al. | Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. | 2011 | PLoS ONE | pmid:21304987 |
Schuchardt M et al. | Pharmacological relevance and potential of sphingosine 1-phosphate in the vascular system. | 2011 | Br. J. Pharmacol. | pmid:21309759 |
López-Juárez A et al. | Expression of LPP3 in Bergmann glia is required for proper cerebellar sphingosine-1-phosphate metabolism/signaling and development. | 2011 | Glia | pmid:21319224 |
Yonamine I et al. | Sphingosine kinases and their metabolites modulate endolysosomal trafficking in photoreceptors. | 2011 | J. Cell Biol. | pmid:21321100 |
Hagen N et al. | Sphingosine-1-phosphate links glycosphingolipid metabolism to neurodegeneration via a calpain-mediated mechanism. | 2011 | Cell Death Differ. | pmid:21331079 |
Bandhuvula P et al. | S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. | 2011 | Am. J. Physiol. Heart Circ. Physiol. | pmid:21335477 |
Jenkins RW et al. | Regulation of CC ligand 5/RANTES by acid sphingomyelinase and acid ceramidase. | 2011 | J. Biol. Chem. | pmid:21335555 |
Törnquist K | Sphingosine 1-phosphate, sphingosine kinase and autocrine calcium signalling in thyroid cells. | 2012 | Acta Physiol (Oxf) | pmid:21338471 |
Pinschewer DD et al. | Impact of sphingosine 1-phosphate modulation on immune outcomes. | 2011 | Neurology | pmid:21339486 |
Mehling M et al. | Clinical immunology of the sphingosine 1-phosphate receptor modulator fingolimod (FTY720) in multiple sclerosis. | 2011 | Neurology | pmid:21339487 |
Hla T and Brinkmann V | Sphingosine 1-phosphate (S1P): Physiology and the effects of S1P receptor modulation. | 2011 | Neurology | pmid:21339489 |
Soliven B et al. | The neurobiology of sphingosine 1-phosphate signaling and sphingosine 1-phosphate receptor modulators. | 2011 | Neurology | pmid:21339490 |
Serebrov VIu et al. | [Activity of the sphingomyelin cycle enzymes and concentration of products of sphingomyelin degradation in the rat liver in the course of acute toxic hepatitis]. | 2010 Mar-Apr | Biomed Khim | pmid:21341516 |
Ruiz-Medina J et al. | GPR3 orphan receptor is involved in neuropathic pain after peripheral nerve injury and regulates morphine-induced antinociception. | 2011 Jul-Aug | Neuropharmacology | pmid:21352831 |
Kikuta J et al. | [Encounter of cancer cells with bone. In vivo imaging of osteoclasts and their precursors in intact bone tissues]. | 2011 | Clin Calcium | pmid:21358058 |
Mair N et al. | Genetic evidence for involvement of neuronally expressed S1Pâ‚ receptor in nociceptor sensitization and inflammatory pain. | 2011 | PLoS ONE | pmid:21359147 |
Ishii T et al. | The role of sphingosine 1-phosphate in migration of osteoclast precursors; an application of intravital two-photon microscopy. | 2011 | Mol. Cells | pmid:21360199 |
Antel J and Hohlfeld R | Modulation of sphingosine 1-phosphate signaling in neurologic disease. | 2011 | Neurology | pmid:21360856 |
Jung M et al. | Anti-ageing effects of a new synthetic sphingolipid (K6EAA-L12) on aged murine skin. | 2011 | Exp. Dermatol. | pmid:21366697 |
Kumar A et al. | S1P lyase regulates DNA damage responses through a novel sphingolipid feedback mechanism. | 2011 | Cell Death Dis | pmid:21368890 |
Yogi A et al. | Sphingosine-1-phosphate-induced inflammation involves receptor tyrosine kinase transactivation in vascular cells: upregulation in hypertension. | 2011 | Hypertension | pmid:21383307 |
Sánchez BA et al. | Targeted analysis of sphingoid precursors in human biofluids by solid-phase extraction with in situ derivatization prior to μ-LC-LIF determination. | 2011 | Anal Bioanal Chem | pmid:21394454 |
Lamana A et al. | CD69 modulates sphingosine-1-phosphate-induced migration of skin dendritic cells. | 2011 | J. Invest. Dermatol. | pmid:21412255 |
Benamer N et al. | Electrophysiological and functional effects of sphingosine-1-phosphate in mouse ventricular fibroblasts. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21420933 |
Roviezzo F et al. | Sphingosine-1-phosphate modulates vascular permeability and cell recruitment in acute inflammation in vivo. | 2011 | J. Pharmacol. Exp. Ther. | pmid:21421740 |
Ocaña-Morgner C et al. | Sphingosine 1-phosphate-induced motility and endocytosis of dendritic cells is regulated by SWAP-70 through RhoA. | 2011 | J. Immunol. | pmid:21421853 |
Kato K et al. | Regulation by heat shock protein 27 of osteocalcin synthesis in osteoblasts. | 2011 | Endocrinology | pmid:21427224 |
Schröder M et al. | The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen. | 2011 | Mol. Immunol. | pmid:21435724 |
Kujjo LL et al. | Chemotherapy-induced late transgenerational effects in mice. | 2011 | PLoS ONE | pmid:21437292 |
Cahalan SM et al. | Actions of a picomolar short-acting S1Pâ‚ agonist in S1Pâ‚-eGFP knock-in mice. | 2011 | Nat. Chem. Biol. | pmid:21445057 |
Brecht K et al. | Macrophages programmed by apoptotic cells promote angiogenesis via prostaglandin E2. | 2011 | FASEB J. | pmid:21450910 |
Lim KG et al. | FTY720 analogues as sphingosine kinase 1 inhibitors: enzyme inhibition kinetics, allosterism, proteasomal degradation, and actin rearrangement in MCF-7 breast cancer cells. | 2011 | J. Biol. Chem. | pmid:21464128 |
Zhu Q et al. | A novel lipid natriuretic factor in the renal medulla: sphingosine-1-phosphate. | 2011 | Am. J. Physiol. Renal Physiol. | pmid:21478479 |
Kennedy AJ et al. | Development of amidine-based sphingosine kinase 1 nanomolar inhibitors and reduction of sphingosine 1-phosphate in human leukemia cells. | 2011 | J. Med. Chem. | pmid:21495716 |
Kartal M et al. | Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. | 2011 | Nutr Cancer | pmid:21500096 |
Jackson EK | Role of sphingosine-1-phosphate in the renal medulla. | 2011 | Am. J. Physiol. Renal Physiol. | pmid:21511695 |
Pyne S and Pyne NJ | Translational aspects of sphingosine 1-phosphate biology. | 2011 | Trends Mol Med | pmid:21514226 |
Cohen JA and Chun J | Mechanisms of fingolimod's efficacy and adverse effects in multiple sclerosis. | 2011 | Ann. Neurol. | pmid:21520239 |
Salas A et al. | Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A. | 2011 | Blood | pmid:21527515 |
Baranowski M et al. | Exercise increases plasma levels of sphingoid base-1 phosphates in humans. | 2011 | Acta Physiol (Oxf) | pmid:21535416 |
Takasugi N et al. | BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. | 2011 | J. Neurosci. | pmid:21543615 |
Separovic D et al. | Combining anticancer agents photodynamic therapy and LCL85 leads to distinct changes in the sphingolipid profile, autophagy, caspase-3 activation in the absence of cell death, and long-term sensitization. | 2011 | Biochem. Biophys. Res. Commun. | pmid:21545791 |
Spiegel S and Milstien S | The outs and the ins of sphingosine-1-phosphate in immunity. | 2011 | Nat. Rev. Immunol. | pmid:21546914 |
Argraves KM et al. | S1P, dihydro-S1P and C24:1-ceramide levels in the HDL-containing fraction of serum inversely correlate with occurrence of ischemic heart disease. | 2011 | Lipids Health Dis | pmid:21554699 |
Gu Y et al. | Epithelial cell extrusion requires the sphingosine-1-phosphate receptor 2 pathway. | 2011 | J. Cell Biol. | pmid:21555463 |
Oo ML et al. | Engagement of S1Pâ‚-degradative mechanisms leads to vascular leak in mice. | 2011 | J. Clin. Invest. | pmid:21555855 |
Finney CA et al. | S1P is associated with protection in human and experimental cerebral malaria. | 2011 | Mol. Med. | pmid:21556483 |
Soleimani R et al. | Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants. | 2011 | PLoS ONE | pmid:21559342 |